ATNT-12PHASE I, TWO-STAGE, OPEN-LABEL, DOSE-ESCALATION STUDY OF BUPARLISIB (BKM120) IN COMBINATION WITH ADJUVANT TEMOZOLOMIDE (TMZ) AND WITH CONCOMITANT RADIATION THERAPY (RT) AND TMZ IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Bibliographic record
Abstract
BACKGROUND: Phase I, two-stage study of buparlisib combined with standard-of-care (RT + TMZ followed by adjuvant TMZ) in newly diagnosed GBM. METHODS: Stage I evaluated buparlisib with adjuvant TMZ in 28-day treatment cycles after prior RT + TMZ treatment. Stage II evaluated buparlisib with concomitant RT + TMZ and then adjuvant TMZ. In the concomitant phase, buparlisib was administered at two schedules: 60mg/40mg/QD or 40mg D1–5/Q7, in combination with RT (2.5 Gy/day) + TMZ 75mg/m2/day over 42 days. In the adjuvant phase, buparlisib was administered at 80mg/QD during Cycle 1 with TMZ 150mg/m2 D1–D5/Q28 (A1), and at 60mg/80mg/QD during Cycles 2–12 with TMZ 200mg/m2 on D1–D5/Q28 (A2). Dose-escalation was guided by a Bayesian logistic regression model with overdose control principle. Primary study objectives were to identify buparlisib dose-limiting toxicities (DLTs) and to determine the recommended Phase II dose (RP2D). RESULTS: Adjuvant: Of 16 patients treated, six developed DLTs, including three DLTs in A1: Grade(G) 3-hyperglycemia, G3-anxiety, G3-intermittent confusion (1 patient each) at 80mg/QD; and three in A2: G2-hyperglycemia (1 patient) at 60mg/QD, G4-platelet count decrease and G4-thrombocytopenia (1 patient each) at 80mg/QD. Concomitant: Of 22 patients treated, seven developed DLTs: G4-thrombocytopenia (2 patients) at 60mg/QD, G4-lipase elevation (2 patients) and G2-thrombocytopenia (1 patient) at 40mg/QD, G3-decreased mood (1 patient) and G4-decreased platelet count (1 patient) at 40mg D1–5/Q7. Twenty-three patients (60.5%) experienced study-drug-related G3/4 adverse events (AEs) including hyperglycemia, neutropenia, thrombocytopenia (13.2% each), and lipase increase (10.5%). Twenty-nine patients discontinued treatment due to AEs (44.7%), disease progression (26.3%), and withdrawal of consent (5.3%). CONCLUSION: RP2D of buparlisib for the adjuvant phase in combination with TMZ was defined as 80mg/QD. RP2D of buparlisib plus RT + TMZ was not determined due to challenging safety at all doses/schedules. Exposure of buparlisib with RT + TMZ was slightly lower than that of single-agent buparlisib. Anti-tumor activity is under evaluation and will be reported.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.002 | 0.001 |
| Meta-epidemiology (narrow) | 0.003 | 0.001 |
| Meta-epidemiology (broad) | 0.003 | 0.002 |
| Bibliometrics | 0.001 | 0.001 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.001 | 0.002 |
| Open science | 0.002 | 0.001 |
| Research integrity | 0.002 | 0.005 |
| Insufficient payload (model declined to judge) | 0.005 | 0.002 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".